2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Jonathan A. Ledermann, BSc, MD, FRCP

Professor of Medical Oncology
University College London
University College London Hospitals
London United Kingdom NW1 2PG

Papers:
13 Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer and a BRCA mutation: overall survival adjusted for post-progression PARP inhibitor therapy